Abstract
A new group of 3-alkyl-2-aryl-1,3-thiazinan-4-ones, possessing a methylsulfonyl pharmacophore, were synthesized and their biological activities were evaluated for cyclooxygenase-2 (COX-2) inhibitory activity. In vitro COX-1/COX-2 inhibition studies identified 3-benzyl-2-(4-methylsulfonylphenyl)-1,3-thiazinan-4-one (11a) as a potent (IC(50)=0.06 microM) and selective (selectivity index >285) COX-2 inhibitor.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Cyclooxygenase 2 Inhibitors / chemical synthesis
-
Cyclooxygenase 2 Inhibitors / chemistry*
-
Cyclooxygenase 2 Inhibitors / pharmacology
-
Drug Design
-
Inhibitory Concentration 50
-
Mice
-
Structure-Activity Relationship
-
Thiazines / chemical synthesis
-
Thiazines / chemistry*
-
Thiazines / pharmacology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Thiazines